GENERAL ATLANTIC PARTNERS LLC 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-07 9:45 pm Sale |
2024-03-07 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 1,747,849 3.500% |
-858,835 (-32.95%) |
Filing |
| 2023-09-18 2:40 pm Sale |
2023-09-15 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 2,606,684 5.300% |
-249,213 (-8.73%) |
Filing |
| 2023-06-15 5:17 pm Sale |
2023-06-13 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 2,855,897 5.900% |
-369,803 (-11.46%) |
Filing |
| 2023-01-17 5:25 pm Sale |
2022-01-12 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 3,225,700 7.100% |
-614,969 (-16.01%) |
Filing |
| 2023-01-03 6:56 pm Sale |
2022-12-29 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 3,840,669 8.480% |
-516,223 (-11.85%) |
Filing |
| 2022-12-20 5:13 pm Sale |
2022-12-16 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 4,356,892 9.620% |
-965,683 (-18.14%) |
Filing |
| 2022-07-21 5:13 pm Purchase |
2022-07-20 | 13D | Immunocore Holdings plc IMCR |
GENERAL ATLANTIC PARTNERS LLC | 5,322,575 11.500% |
5,322,575 (New Position) |
Filing |